Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Scientists have developed a new way to use information from your genes or proteins to help doctors diagnose or treat diseases ...

Kettering, is hoping the third time's the charm on her effort to require private insurers to cover "biomarker" medical testing and thereby improve health outcomes in Ohio and cut down on personal ...

House Bill 8, has been introduced in Ohio with the goal of expanding private insurance and Medicaid coverage for biomarker ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

But detecting and treating the condition early can help slow its progression. Now, new research published in the journal ...

Now, new research published in the journal Nature Medicine suggests that a special biomarker test could help detect signs of Alzheimer’s disease up to a decade before they begin to show up on ...

Study highlights concerns about premature adoption of preeclampsia screening tests, emphasizing the need for clinical utility trials before widespread implementation.

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...